V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158458 | 20060679 | 1.8 | 79.8 | Neo-adjuvant (N) | 2017-12-29 | 2017-12-29 | ECX | N | N | ECX | 100948545 |
| 20158459 | 20060680 | null | null | Neo-adjuvant (N) | 2016-09-28 | 2016-09-29 | ECX | 02 | N | ECX | 100791083 |
| 20158461 | 20060681 | 1.8 | 81 | Palliative (P) | 2017-10-13 | 2017-10-14 | ECX | 02 | N | ECX | 100355211 |
| 20158462 | 20060682 | 1.53 | 61.8 | Palliative (P) | 2017-02-28 | 2017-03-07 | ECX | N | N | ECX | 100407757 |
| 20158464 | 20060683 | 1.64 | 57 | Palliative (P) | 2017-11-19 | 2017-12-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100962992 |
| 20158466 | 20060684 | 1.56 | 65.8 | null | 2019-01-17 | 2019-02-01 | CAPECITABINE + GEMCITABINE | Y | N | CAPECITABINE + GEMCITABINE | 100670079 |
| 20158467 | 20060685 | 1.82 | 64 | Adjuvant (A) | 2018-10-06 | 2018-10-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100308781 |
| 20158468 | 20060686 | 1.78 | 91 | Neo-adjuvant (N) | 2018-09-21 | 2018-09-21 | ECX | N | Y | ECX | 100206077 |
| 20158469 | 20060687 | 1.84 | 93.3 | Curative (C) | 2018-05-20 | 2018-06-03 | ECX | 02 | N | ECX | 100636166 |
| 20158470 | 20060688 | 1.76 | 92.8 | Curative (C) | 2016-03-03 | 2016-03-03 | ECX | N | N | ECX | 101468472 |
| 20158471 | 20060689 | 1.71 | 55.9 | Palliative (P) | 2019-03-04 | 2019-03-24 | ECX | N | N | ECX | 101774093 |
| 20158472 | 20060690 | 1.71 | 101.8 | Neo-adjuvant (N) | 2017-07-09 | 2017-08-03 | ECX | N | N | ECX | 100020620 |
| 20158475 | 20060691 | 1.76 | 88 | Adjuvant (A) | 2019-03-16 | 2019-03-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101073167 |
| 20158478 | 20060692 | 1.76 | 81 | Neo-adjuvant (N) | 2018-05-28 | 2018-05-28 | ECX | N | N | ECX | 100938695 |
| 20158479 | 20060693 | 1.86 | 60 | Neo-adjuvant (N) | 2019-12-01 | 2019-12-17 | ECX | 02 | N | ECX | 100934924 |
| 20158480 | 20060694 | 1.71 | 73 | Curative (C) | 2016-07-04 | 2016-07-04 | ECX | 2 | N | ECX | 100890036 |
| 20158481 | 20060695 | 1.59 | 82.2 | Adjuvant (A) | 2019-12-13 | 2019-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100196681 |
| 20158482 | 20060696 | 1.65 | 51.85 | Palliative (P) | 2018-06-03 | 2018-06-24 | ECX | N | null | ECX | 100992651 |
| 20158484 | 20060697 | 1.72 | 101 | Neo-adjuvant (N) | 2017-02-21 | 2017-02-21 | ECX | N | null | ECX | 101564863 |
| 20158485 | 20060698 | 1.69 | 63.6 | Palliative (P) | 2018-06-09 | 2018-06-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100946278 |
| 20158487 | 20060699 | 1.71 | 57.7 | Neo-adjuvant (N) | 2018-08-20 | 2018-08-24 | ECX | 2 | N | ECX | 101391132 |
| 20158489 | 20060700 | 1.8 | 90.5 | Adjuvant (A) | 2016-05-15 | 2016-05-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101209583 |
| 20158490 | 20060701 | 1.64 | 59 | Adjuvant (A) | 2016-07-25 | 2016-07-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100476225 |
| 20158492 | 20060702 | 1.6 | 52 | Palliative (P) | 2019-02-23 | 2019-03-02 | ECX | N | N | ECX | 100545871 |
| 20158495 | 20060703 | 1.74 | 56.7 | Palliative (P) | 2018-10-05 | 2018-11-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100129338 |
| 20158497 | 20060704 | 1.63 | 75 | Neo-adjuvant (N) | 2018-05-29 | 2018-06-04 | ECX | N | N | ECX | 100854565 |
| 20158498 | 20060705 | 1.62 | 82.6 | Palliative (P) | 2016-04-06 | 2016-04-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101177669 |
| 20158499 | 20060706 | 1.62 | 65 | Curative (C) | 2018-05-17 | 2018-05-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100763196 |
| 20158500 | 20060707 | 1.7 | 82.6 | Curative (C) | 2016-09-17 | 2016-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101464867 |
| 20158502 | 20060708 | 1.79 | 78 | Neo-adjuvant (N) | 2019-02-12 | 2019-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101334721 |
| 20158503 | 20060709 | 1.76 | 81 | Palliative (P) | 2019-12-25 | 2020-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100417948 |
| 20158504 | 20060710 | 1.56 | 61.3 | Neo-adjuvant (N) | 2017-07-07 | 2017-07-14 | ECX | N | N | ECX | 100245871 |
| 20158506 | 20060711 | 1.76 | 75.9 | Palliative (P) | 2019-07-06 | 2019-07-13 | ECX | 02 | N | ECX | 100818176 |
| 20158508 | 20060712 | 1.54 | 58.3 | Neo-adjuvant (N) | 2017-11-14 | 2017-11-26 | ECX | N | N | ECX | 101545245 |
| 20158509 | 20060713 | 1.58 | 56.8 | Adjuvant (A) | 2017-04-06 | 2017-05-02 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100658098 |
| 20158511 | 20060714 | null | 156 | Palliative (P) | 2018-03-05 | 2018-03-13 | ECX | 02 | N | ECX | 101576354 |
| 20158512 | 20060715 | 1.8 | 83 | Neo-adjuvant (N) | 2017-12-04 | 2018-01-09 | ECX | N | null | ECX | 100321626 |
| 20158514 | 20060716 | 1.68 | 73 | null | 2020-04-01 | 2020-04-20 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101250313 |
| 20158515 | 20060717 | 1.81 | 52.3 | Adjuvant (A) | 2017-06-16 | 2017-07-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100424892 |
| 20158519 | 20060718 | 1.56 | 48 | Palliative (P) | null | 2019-01-24 | ECX | N | N | ECX | 100992363 |
| 20158522 | 20060719 | 1.64 | 53.3 | Adjuvant (A) | 2019-04-29 | 2019-05-04 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100382076 |
| 20158527 | 20060720 | 1.5 | 51 | Palliative (P) | null | 2019-03-25 | Gemcitabine + Capecitabine | null | N | ECX | 101633905 |
| 20158528 | 20060721 | 1.7 | 78.5 | Radical (R) | 2016-12-21 | 2017-01-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101050951 |
| 20158529 | 20060722 | 1.65 | 80.4 | Palliative (P) | 2016-08-15 | 2016-09-12 | ECX | N | N | ECX | 100494265 |
| 20158530 | 20060723 | 1.81 | 114.6 | Adjuvant (A) | 2017-01-08 | 2017-01-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101588047 |
| 20158531 | 20060724 | 1.63 | 129.8 | Palliative (P) | 2018-04-04 | 2018-04-12 | ECX | N | N | ECX | 101400737 |
| 20158533 | 20060725 | 1.65 | 77.7 | null | 2018-06-13 | 2018-09-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101273383 |
| 20158535 | 20060726 | 1.71 | 67.1 | Adjuvant (A) | 2019-08-17 | 2019-09-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101358208 |
| 20158539 | 20060727 | 1.5 | 82.3 | Palliative (P) | 2018-07-30 | 2018-08-09 | ECX | N | N | ECX | 101629447 |
| 20158540 | 20060728 | 1.59 | 87.4 | Neo-adjuvant (N) | 2019-05-24 | 2019-06-07 | ECX | N | null | ECX | 101212632 |